Publications by authors named "M Ocal"

Objective: The aim of our study was to compare serum MOTS-c levels in children with Type 1 diabetes mellitus (T1DM) to those of healthy children. We also aimed to examine whether serum MOTS-c levels could be used as an early indicator of DKD by correlating with changes in GFR and microalbuminuria.

Methods: We recruited 82 patients who were being treated for insulin-dependent diabetes at the outpatient pediatric endocrinology clinic.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetic ketoacidosis (DKA) can lead to hyperchloremic metabolic acidosis (HMA) due to chloride overload from intravenous hydration, which may prolong acidosis even after ketonemia resolves.
  • In a study of 178 DKA episodes, hyperchloremia was found in 69.3% of patients, developing about 6.3 hours into treatment, with severity increasing over time.
  • Monitoring additional parameters like anion gap and chloride-corrected bicarbonate can help distinguish DKA from HMA, potentially reducing the duration of intravenous treatment.
View Article and Find Full Text PDF

Purpose: Phenotypic methods have been proposed for the detection of carbapenemase production. These tests can have slower turnaround times. With the sensitivity-based algorithm described by Gill et al.

View Article and Find Full Text PDF

Background/aim: The role of PD-L1 in regulating the immunosuppressive tumor microenvironment via its binding on PD-1 receptors is extensively studied. The PD-1/PD-L1 axis is a significant way of cancer immune escape, and PD-L1 expression on tumor cells is suggested as a predictive marker for anti-PD-1/PD-L1 monoclonal antibodies (MoAbs). However, the tumor-intrinsic role of PD-L1 is not known well.

View Article and Find Full Text PDF

As more antibiotics become ineffective due to drug-resistant bacteria, alternative therapies for infections must be prioritized. While pathogenic bacteria are a major threat, they also supply a massive reservoir of potential drugs for treating a wide range of illnesses. The concerning emergence of antimicrobial resistance and the rapidly dwindling therapeutic pipeline need the quick discovery and development of new antibiotics.

View Article and Find Full Text PDF